Oritavancin (phosphate)

Oritavancin (phosphate)

CAT N°: 24091
Price:

146.00 124.10

Oritavancin is a semisynthetic glycopeptide antibiotic that inhibits the growth of Gram-positive bacteria.{39468} It inhibits transglycosylation and transpeptidation in the bacterial cell wall to disrupt membrane integrity.{39469,39470} Oritavancin inhibits the growth of clinical isolates from skin and soft-tissue infections, including methicillin-resistant and -susceptible S. aureus (MRSA, MSSA), vancomycin-resistant and -susceptible E. faecium (VREF, VSRF), as well as other staphylococci, streptococci, and enterococci (MIC90s = ?0.008-0.5 mg/L).{39471} Oritavancin inhibits growth of S. aureus in a neutropenic-mouse thigh model of infection (ED50 = 0.95 mg/kg for a single dose).{39472} It improves survival in a mouse inhalation model of B. anthracis Ames anthrax when administered prophylactically pre- and postexposure and when administered post symptom development.{39473} Formulations containing oritavancin have been used to treat bacterial skin infections.

We also advise you